Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Communication Disorders × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 250 Glioblastoma 223 Glioma 143 Astrocytoma 92 Central Nervous System Neoplasms 67 Gliosarcoma 63 Oligodendroglioma 57 Neuroblastoma 56 Neoplasms 48 Breast Neoplasms 43 Melanoma 39 Carcinoma, Non-Small-Cell Lung 37 Neoplasm Metastasis 30 Lymphoma 28 Recurrence 26 Medulloblastoma 26 Lung Neoplasms 26 Ependymoma 21 Ovarian Neoplasms 19 Lymphoma, Follicular 18 Sarcoma 17 Precursor Cell Lymphoblastic Leukemia-Lymphoma 17 Lymphoma, Non-Hodgkin 17 Leukemia 17 Meningioma 16 Burkitt Lymphoma 16 Multiple Myeloma 15 Meningeal Carcinomatosis 15 Lymphoma, Large B-Cell, Diffuse 15 Carcinoma, Renal Cell 15

Interventions

Speech Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05189366 2025-10-07

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡